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Abstract The causes of prostate cancer are still obscure
but some evidence indicates that there is a close connection
between several trace elements and processes which may
lead to malignant cells. In our study the microbeam syn-
chrotron radiation X-ray ﬂuorescence emission (micro-
SRIXE) technique was applied for quantitative analysis of
selected elements. For the ﬁrst time, we correlate the
concentrations of Mn, Fe, Cu, and Zn with the clinical
stage of the prostate cancer at the time of operation
(described by Gleason grade). Serial sections of prostate
tissues were collected from patients undergoing radical
prostatectomy. One section, stained with hematoxylin and
eosin, was prepared for histopathological analysis; a sec-
ond, adjacent unstained section was used in micro-SRIXE
experiments. All experiments were performed at beamline
L at HASYLAB, DESY, Germany. Our results seem to be
valuable in light of the determination of the changes in the
concentrations of trace elements as a potential diagnostic
marker and their etiological involvement in the different
stages of prostate diseases.
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Introduction
The prostate is a small, squishy gland the size of a walnut
that is situated under the bladder and in front of the rectum.
Male hormones are responsible for growth of the prostate
gland in the fetus. The prostate gland grows until a man
reaches adulthood and then stays about the same size as
long as male hormones are produced [1].
Prostate cancer is the most frequently diagnosed cancer
in men and is the second leading cause of cancer death [2].
Intensiﬁed screening efforts in recent years and the use of
prostate-speciﬁc antigen as a marker of disease have
resulted in increased diagnosis of early-stage disease.
Although researchers still do not know exactly what causes
prostate cancer, they have identiﬁed some factors that
increase the risk of getting it: age, family history, ethnicity,
diet, and obesity [1–3]. Prostate cancer occurs when cells
in the prostate gland grow and multiply uncontrollably. The
nodular tumor mass invades the surrounding tissues and
eventually spreads to the lymph nodes, skeletal bones, and
other regions of the body. Although several cell types are
found in the prostate, over 99% of prostate cancers develop
from the glandular cells and are therefore described as
adenocarcinoma [3, 4].
Over the past 15 years, more detailed descriptions of
cancers have been given by pathologists; prostate tissues
A. Banas  W. M. Kwiatek  K. Banas
Institute of Nuclear Physics,
Polish Academy of Sciences,
Radzikowskiego 152, 31-342 Krako ´w, Poland
A. Banas (&)  K. Banas
Singapore Synchrotron Light Source (SSLS),
National University of Singapore,
5 Research Link, Singapore 117603, Singapore
e-mail: slsba@nus.edu.sg
M. Gajda  T. Cichocki
Department of Histology, Collegium Medicum,
Jagiellonian University, Kopernika 7,
31-034 Krako ´w, Poland
B. Pawlicki
Gabriel Narutowicz Hospital, Pra ˛dnicka 37,
31-202 Krako ´w, Poland
123
J Biol Inorg Chem (2010) 15:1147–1155
DOI 10.1007/s00775-010-0675-5were classiﬁed using a new tool—Gleason grade [5–7].
This system is based on the architectural patterns of cancer
glands observed by the pathologist under the microscope
(Fig. 1). Whether or not the cancer is likely to grow slowly
or very quickly depends on, according to Gleason grading,
how closely the cells of the cancer resemble normal cells.
Those cells that look like normal glandular tissue with
some cancer cells in the lining are termed as ‘‘well-dif-
ferentiated cancers.’’ They have a low Gleason grade (1 or
2), grow slowly, and take a long time to become clinically
signiﬁcant.
Cells that appear very little like normal glands and more
like sheets of packed cancer cells are termed ‘‘poorly dif-
ferentiatedcancers’’(Gleasongrade4or5);thesetumorsare
very aggressive and most treatments have poor results.
Finally,cellswhichformmultiplesmallglandularspacesare
in the middle of the Gleason grade scale and are called
‘‘moderatelywelldifferentiatedcancers’’(Gleasongrade3).
Undoubtedly, Gleason grading provides much valuable
information in terms of prostate cancer classiﬁcation, but a
limitation of this technique is the disparity between tissue
architecture and its biochemical status. Understanding what
exactly happens when prostate cancer begins to grow
seems to be very important; it may also help in selection of
reliable treatment options and it could help save many
men’s lives.
There is still a need for additional markers which could
increase the sensitivity and speciﬁcity of prostate cancer
detection and also aid in the selection of the therapy for the
treatment of disease. Some authorities in urology have
suggested that all new prognostic markers should be
evaluated in conjunction with Gleason grade [8].
For many years studies of the concentration of trace
elements have played an important role in ﬁeld of better
understanding of different processes occurring in cells.
Instability (overabundance or deﬁciency) in the composi-
tion of trace metals that are recognized to be essential to
normal human homeostasis and the accumulation of
potentially toxic or nonessential trace metals may lead to
different diseases. It was also proven that some trace ele-
ments play a critical role in cancer biology; however, there
is still a serious lack of information concerning their
function in initiation, promotion, and inhibition of carcin-
ogenic processes in prostate glands [9–15]. Thus, there is a
real need for analysis of trace elements in cancerous and
noncancerous human tissues to examine the relationship
between cancer and these elements. Detailed in situ studies
are necessary if the role of metal accumulation in the
structural and functional changes produced by the disease
are to be understood.
Of the many methods suitable for detection of the con-
centration of elements in biological tissues, the most pre-
ferred are multielemental highly sensitive analytical
techniques such as synchrotron radiation X-ray ﬂuorescence
emission (SRIXE). In our work we used synchrotron radia-
tion to detect and locate selected trace elements in postop-
erative samples of prostate tissues at cellular and subcellular
(especially in the case of cancerous cells) resolution. Fluo-
rescence spectra provide a fast and sensitive means of
detectinganomalousmetalconcentrationsinatissuesection,
andbecauseofahigh-intensityfocusedbeamitispossibleto
locate the concentrations of selected elements within a few
microns. In our studies we focused mainly on analysis of the
traceelementsMn,Fe,Cu,andZnowingtotheirvitalrolesin
the biochemistry of all living cells. Their concentrations
were determined in cancerous prostate tissues at different
stages of disease described by Gleason grade (2, 3, and 4).
Additionally, healthy and hyperplastic prostate tissues were
analyzed. Our studies were carried out to understand the
effects of altered homeostasis of selected elements in the
origination of prostate cancer.
Materials and methods
Samples
All materials (prostate glands) were obtained during radical
prostatectomies from 12 patients (patients’ age 56–72
years, mean age 61) at the Department of Urology, Szpital
Miejski Specjalistyczny im. Gabriela Narutowicza, Krako ´w,
Poland.
Fig. 1 Hematoxylin- and eosin-stained prostate cancer tissue of
Gleason grades 2–4, exhibiting examples of malignant glands that
were used to acquire microbeam synchrotron radiation X-ray
ﬂuorescence emission (micro-SRIXE) spectra: a Gleason grade 2,
b Gleason grade 3, c Gleason grade 4
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environment to eliminate or at least minimize any con-
tamination effects. All samples were prepared in the same
way. First, material dedicated for analysis was frozen in
liquid nitrogen to stop all living processes occurring in
cells and hence to avoid any alteration in the concentra-
tions of all elements. Then, all specimens were cut into
14-lm slices with the use of a cryomicrotome; for micro-
SRIXE experiments over 100 samples were prepared, and
each slice was mounted on Mylar foil and air-dried. For
every experimental sample, an adjacent section (of the
same thickness) was placed on a microscope glass, and was
then stained with hematoxylin and eosin (H&E) dye.
An experienced histopathologist fully characterized
H&E-stained sections microscopically by dividing them
into noncancerous (healthy and hyperplasic prostate tis-
sues) and cancerous groups; additionally, the Gleason
grade was assigned to areas of malignancy. We obtained
the parts of prostate glands classiﬁed as healthy, hyper-
plastic, Gleason grade 3 and 4 from two patients and the
parts classiﬁed as Gleason grade 2 from four patients. The
histopathologist identiﬁed areas of abnormal cell growth
and found the areas of the cancer; its appearance was
compared with the Gleason scale system to determine
where it falls on a scale of 1–5. All samples used in this
work were analyzed by the same person.
From histopathology studies certain areas were selected
for further micro-SRIXE studies and were used as land-
marks to position the microbeam on the lesions of the
unstained adjacent section. Careful analysis of selected
samples was made using an Olympus BX-50 microscope.
We did not observe any damage in sample patterns, which
would be caused by the Leidenfrost effect [16]. Examples
of H&E-stained sections analyzed during the experiments
are presented in Fig. 1.
Measurements
The spectra were collected at beamline L at HASYLAB,
DESY (Germany), using the synchrotron X-ray ﬂuores-
cence microprobe. The photon ﬂux delivered by the
bending magnet at HASYLAB (positron energy 4.45 GeV,
storage ring current 140 mA, and magnetic ﬁeld 1.2182 T)
is 5 9 10
13 photons/mrad
2/0.1% bandwidth at 10 keV. The
microprobe setup is a powerful instrument for simultaneous
multielement trace analysis of microsamples (http://www.
hasylab.de)[ 17–19].
The micro-SRIXE observation was conducted in air
without pretreatment and staining of samples. Using
this highly brilliant synchrotron source at HASYLAB,
one can routinely detect elements with atomic numbers
between 13 and 92 with minimum detection limits down to
0.1 pg/lg. The white beam of a bending magnet source
was monochromatized by a double-multilayer monochro-
mator with bandpass DE/E % 2%. The photon ﬂux at the
sample with a Si(111) monochromator was 9 9 10
9 pho-
tons/mm
2/0.01% bandwidth at 10 keV. The beam was
focused by a polycapillary half lens (X-ray Optical Sys-
tems, focal distance 4.8 mm and transmission of 30%) and
its size on the sample was approximately 15 lm (in
diameter), which is of the order of a cell diameter. For our
study the energy was set to 17 keV. By using this energy,
we could collect ﬂuorescence spectra with very well
determined peaks for Ka lines of elements with atomic
number between 15 and 38. Figure 2 depicts an example
spectrum collected from a healthy prostate sample.
All experiments were performed on individual samples
placed on 2.5-lm Mylar foil. This foil is strong enough to
support the tissue, and it can also withstand the focused
beam. Additionally, what is the most important aspect for
our analysis, measurements made on this foil gave a clean
background in terms of the ﬂuorescence signal of the ele-
ments of interest.
During analyses the samples were ﬁxed on a remote-
controlled stage equipped with high-precision stepping
motors allowing for micrometric movements in xyz space
(reproducible positioning of about 0.5 lm). The samples
on the special holder were positioned at an angle of 45
with respect to the incoming beam, just in front of the
polycapillary (Fig. 3).
X-ray ﬂuorescence was detected by use of a conven-
tional high-purity Ge X-ray detector (with an energy res-
olution of 120 eV at 5.89 keV) positioned at 90 to the
incoming linearly polarized X-ray beam and placed in the
storage ring plane to minimize the intensity of the scat-
tering X-rays. The beryllium window of the detector was
8 lm thick. The air path between the samples and the
detector was set to a few millimeters; it was set after
several tests to optimize the experimental conditions. The
Fig. 2 Micro-SRIXE spectrum collected from healthy prostate tissue
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123acquisition time of a single spectrum was 300 s in order to
obtain reliable spectra with good signal-to-noise ratio. Only
areas previously selected by the histopathologist were
analyzed. On the same type of cell packaging, single points
were measured with a distance of around 15–20 lm
between them. If there were any signiﬁcant discrepancies
between the spectra collected for these points, additional
examinations were performed by the histopathologist.
The spectra collected were deconvolved by using the
AXIL program [20]. The evaluation of energy-dispersive
X-ray spectra by means of AXIL was achieved by ﬁtting
the measured spectra with suitable mathematical functions,
using a nonlinear least-squares strategy. A special model
including information about the Gaussian line shape cen-
tered around the proper energy, positions of the lines, their
relative amplitudes, the distance between the Ka and Kb
lines, the shape of the background, etc. was created prior to
analysis of the actual spectrum using the X-ray library
available in the software. In the analysis presented, the
smooth ﬁlter background was chosen. The smooth ﬁlter
procedure is based on the removal of rapidly varying
structures in a spectrum by comparing the channel content
yi with the channel content of its neighbors. For each
spectrum the background was subtracted. Additionally, all
spectra were normalized to the value of the incident photon
ﬂux.
For dry mass concentrations of the elements in the
samples analyzed (expressed in micrograms per gram) two
gelatine homemade standards were prepared [21]. Standard
MULT I consisted of a mixture of nitrates of metals such as
Ca, V, Fe, Zn, As, Pb, Sr, Zr, Mo, and Cd, whereas MULT
II included K, V, Mn, Fe, Zn, Hg, Pb, Sr, Zr, and Mo.
The metal concentrations in those standards were 10 lg/g,
which was additionally conﬁrmed by atomic absorption
spectroscopy.
For calculation of the concentrations for Mn, Fe, Cu,
and Zn ‘‘the external standard method’’ was used [22].
Results and discussion
Statistical analysis
Statistical analysis and graphic presentation of the data
were done with the R platform (version 2.10) [23]. To
check the normality of the distribution of the concentra-
tions obtained and to select the correct method for further
analysis of the data collected, the Shapiro–Wilk test was
performed. This test is tailored to access the goodness of
the ﬁt to the normal distribution and is considered a better
choice than Kolmogorov–Smirnof and Lilliefors tests.
According to the results of this test, all distributions of the
concentrations of the selected elements were not normal
(with P \0.05), which is understandable in the case of
analysis of biological samples because several factors may
contribute to the concentration range of the results, such as
differences in diet, hormonal status, age, genetics, and drug
administration.
Over 300 spectra collected during the experiments from
different samples were taken into account in the statistical
analysis. The average number of spectra for each group of
prostate tissues (healthy, hyperplastic, Gleason grades 2–4)
was 60. For every element under consideration, basic
descriptive statistical parameters were calculated (median,
minimum and maximum, skewness, and curtosis values).
Median values were chosen since the concentration distri-
butions of the elements were asymmetric. Almost all the
distributions of elemental content within the different
groups of specimens are positively skewed, which is typi-
cal for biological media [24].
Violin plots [25] were selected to present the results of
the statistical analysis. They are similar to box plots, except
that they also show the probability density of the data at
different values. As shown in Figs. 4, 5, 6, and 7, the violin
plot includes a box plot with two slight modiﬁcations. First,
a circle replaces the median line, which facilitates quick
comparisons when viewing multiple groups. Second, out-
side points which are traditionally classiﬁed as outliers are
not identiﬁed by individual symbols. The kernel density
estimation overlaid on the box plot supplements traditional
statistics by graphically showing the distributional char-
acteristics of data.
For the concentration distributions of Mn, Cu, and Zn
we observed a wide spread of values for the Gleason grade
2 group (Figs. 4, 6, 7), whereas for the other groups this
spread is narrower (except for Zn in hyperplastic tissue);
this may be connected with the fact that the Gleason grade
2 group is represented by material taken from four different
Fig. 3 The experimental table showing the sample holder arrange-
ment at beamline L at HASYLAB
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these elements in this group. For the Fe concentration
distribution, a wide spectrum of values is observed for
Gleason grade 3 and 4 groups (Fig. 5).
Manganese
Manganese is a crucial trace element found in all tissues,
and it is required for normal amino acid, lipid, protein,
and carbohydrate metabolism; it is also necessary in
reproduction, including sex hormone production, and the
functioning of the mammary glands and in the nourishment
of nerve and brain cells. It is vital to thiamine (vitamin B1)
metabolism and tocopherol (vitamin E) utilization [26, 27].
Manganese takes part directly in the defense of red blood
cells, in the metabolism of Fe, and in the synthesis of
cholesterol in the membranes and oligosaccharides.
During our studies no signiﬁcant differences between
concentrations (median values) for Mn in healthy and hy-
perlastic prostate tissue were observed (Fig. 4). This may
Fig. 4 Overview of statistical
analysis of Mn concentration in
tissue specimens
Fig. 5 Overview of statistical
analysis of Fe concentration in
tissue specimens
Fig. 6 Overview of statistical
analysis of Cu concentration in
tissue specimens
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two groups. But the situation changes dramatically for one
of the ﬁrst prostate cancer stages, in our analysis designated
as Gleason grade 2. For these tissues the highest concen-
tration of Mn was noted, almost 10 times higher than for
healthy and hyperplastic groups. This fact may reﬂect the
role which Mn plays in cancerogenesis. Although Mn
deﬁciency is extremely rare in humans, toxicity of Mn is
more prevalent [28]. Manganese as one of the transition
metals is able to catalyze the Fenton reaction, under certain
conditions, when these metal ions are not bound to proteins
or chelators. A Fenton-like reaction may take place and
cause site-speciﬁc accumulation of free radicals and initiate
biomolecular damage processes. Free radicals can cause
tissue damage by reacting with polyunsaturated fatty acids
in cellular membranes, nucleotides in DNA, and critical
sulfhydryl bonds in proteins. There is some evidence that
free-radical damage contributes to the origination of many
chronic health problems, such as emphysema, cardiovas-
cular and inﬂammatory diseases, cataracts, and cancer
[29]. It seems that the elevated level of Mn observed in
the Gleason grade 2 group may enhance prostatic carcino-
genesis.
On the other hand, Mn plays a signiﬁcant role in the
free-radical defense system as manganese superoxide dis-
mutase, which protects mitochondria, the endothelial cells,
and red blood cells from the damage caused by superoxide
radicals. The decreasing amount of Mn observed for more
advanced stages of cancer (Gleason grades 3 and 4) com-
pared with the Gleason 2 group is probably connected with
loss in activity of manganese superoxide dismutase [30].
Iron
Iron is essential for the normal physiological functions in
humans, as an integral part of many proteins and enzymes.
It also plays a vital role in the regulation of cell growth and
in cell differentiation [31, 32]. Physiological maintenance
of relatively constant levels of Fe is crucial, since both Fe
deﬁciency and Fe overload are harmful, and can contribute
to disease development in several ways. Iron overload is
associated with several chronic diseases, such as heart
disease [33, 34], cancer [11, 12, 14, 15, 35], diabetes [36],
and defective immune regulatory control [37]. Iron can
both cause and promote cancer. Any unregulated level of
Fe
2? has the potential to catalyze and generate hydroxyl
radicals from superoxide and hydrogen peroxide via the
Fenton reaction. The highly reactive hydroxyl radicals
subsequently cause lipid peroxidation and degradation of
other macromolecules, leading to cell damage or death
[38–40]. Iron also contributes to disease development by
functioning as a nutrient for microbial and neoplastic cells
[41, 42]. Iron promotes inﬂammation and an increase in
cancer cell growth [43]. The important role of Fe in
stimulating angiogenesis has also been suggested [44].
In the present study, higher levels of Fe were observed
in the malignant prostate tissues relative to the noncan-
cerous tissues (healthy and hyperplastic groups). It is worth
noting that the concentrations for this element increased
with advancement of the cancer stage: about 3 times for
Gleason grades 2 and 3. The highest level was observed for
the Gleason grade 4 group (almost 6 times higher com-
pared with healthy prostate tissue), which may prove that
despite its metabolic essentiality, Fe is somehow involved
in cancerogenesis. There is a hypothesis that high body Fe
stores increase the risk of cancer in men [45].
Copper
In normal conditions Cu is found in all living cells. This
element is fundamental for a wide range of biochemical
processes, but it is also a potentially toxic substance.
Elevated concentrations of Cu (in comparison with
healthy tissues) observed not only in cancerous tissues
(Gleason grades 2, 3, and 4) but also in hyperplastic ones
(Fig. 6) may indicate that this element is linked with some
Fig. 7 Overview of statistical
analysis of Zn concentration
in tissue specimens
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123dysfunction occurring in prostate cells. This dysfunction is
strongly stressed for the Gleason grade 2 group, where the
highest concentration—about 15 times higher than in
healthy prostate—is observed. Copper is one of the pro-
moters of the Fenton reaction; changing its oxidation state,
it can cause harmful effects on the functioning of the cell
through the generation of highly reactive oxygen species,
which produce hydroxyl radicals that adversely modify
proteins, lipids, and nucleic acids [46, 47]. Cell damage
caused by oxygen free radicals may signify the prominent
role of Cu in the ﬁrst stage of neoplasm formation (Gleason
grade 2).
Copper is also believed to be the switcher that turns on
angiogenesis in tumor cells. It has been observed that
abnormally high serum Cu levels are found in patients with
many types of progressive tumors [48–50]. Maybe the
highest level of Cu observed in the Gleason grade 2 group
is also connected with the production of new blood vessels,
which are used for ‘‘feeding’’ the tumors.
Like Mn, Cu has also been recognized to play an
important role as a cofactor of superoxide dismutase [38].
According to our analysis, the concentration of Cu is
decreased with more advanced stage of prostate cancer;
maybe this is linked to a reduction in the defensive capa-
bility of cells.
Zinc
Zinc is a vital element in the nutrition of humans, animals,
and plants. Although most experimental data have demon-
strated the adverse effects of Zn deﬁciency on human and
animal health, there is still evidence to support the
hypothesis that Zn toxicity can also result in deleterious
health effects [51–53]. Conﬂicting views have been
expressed regarding the role of Zn in carcinogenesis. Some
studies [54,55] emphasize the fact that Zn deﬁciency causes
cancers, whereas others [53, 56, 57] highlight that Zn is
involved in tumor growth and development of neoplastic
transformation. These conﬂicting observations suggest that
the role of Zn in different organs may be different.
According to works by Ho and Song [58] and Sapota et al.
[59], the prostate contains the highest concentration of Zn of
all the soft tissues; in prostate cancer this level decreases
rapidly. Our studies reported earlier [15] showed that
prostate cancer tissues contain elevated concentrations of
Zn when compared with normal (healthy) prostate tissues.
In our present studies we still try to sustain the
hypothesis mentioned earlier about the inﬂuence of Zn on
prostate cancer. The highest Zn concentration observed in
Gleason grade 2 tissue (almost 6 times higher compared
with healthy prostate tissue) illustrates the fact that every
highly proliferating cell system is dependent on sufﬁcient
availability of Zn [60].
Zinc is also as an essential element for the immune
system [61, 62]. Its concentration has to be balanced for the
proper functioning of the immune system since both an
increased and a decreased amount of this element result in
a disturbed immune function. Alterations in immune
function increase the risk of several diseases, including
cancer.
The elevated concentration of Zn possibly leads to the
development of various disorders in the prostate gland. A
higher concentration of Zn in hyperplastic prostate tissues
compared with healthy ones was also observed by Sapota
et al. [59]. In our analysis we noted an increase in the
concentration also for Gleason grade 2, 3, and 4 groups, but
it is worth mentioning that the concentration for this ele-
ment gradually decreases for more advanced Gleason
grades; the same trends were observed for Mn and Cu
concentrations.
Summary of the statistical results
To validate our observations and conﬁrm their statistical
importance, the Wilcoxon signed rank test for unpaired
samples was used. A summary of the results is presented in
Table 1. The P values are the products of nonparametric
comparison between the groups representing the healthy
and diseased tissue samples. P values lower than the cutoff
point of 0.05 indicate that the two groups differ signiﬁ-
cantly with respect to the property that was used for the
comparison. The results obtained indicate that in the most
of the cases the selected elements signiﬁcantly differentiate
the groups analyzed; a weaker dependence is observed for
Zn in distinguishing between hyperplastic–Gleason grade 3
and hyperplastic–Gleason grade 4 groups.
Neither Fe nor Mn can be used to discriminate between
healthy and hyperplastic prostate tissue; similarly, Fe
cannot be a good indicator for differences between Gleason
grade 2 and 3 groups.
Conclusions
Our studies were undertaken to establish the variations in
trace element concentrations between healthy tissues, hy-
perlastic tissues, and tissues in different stages of prostate
cancer and to understand the effects of altered homeostasis
of these elements in the origination of prostate cancer.
We have shown that the combination of element dis-
tribution patterns of prostate tissues with an appropriate
statistical technique can be used as a useful tool for dis-
tinguishing normal tissues from various stages of cancer.
The violin plots presented here synergistically combine
box plots and the density trace into a single display that
reveals structures found within the data.
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cancerous prostate tissues could be either a cause or a
consequence of the pathological stages. Concerning the
role of trace elements in the origination or advancement of
prostate cancer, one possible surmise is that the raised
levels of Mn, Fe, and Cu could have led to the formation of
free radicals or other reactive oxygen species that adversely
affect DNA, thereby causing prostate cancer. Additionally,
because Cu and Fe are expected to initiate angiogenesis,
elevated concentrations of these elements are likely to
promote prostate cancer by increasing the blood supply for
tumor growth. The elevated Zn concentrations observed in
the present work may indicate that this element is required
in neoplastic transformation and tumor growth.
On the other hand, elevated concentrations of elements
in tissues in different stages of prostate cancer might also
be a consequence of this disease. It is widely known that
normal and cancerous tissues differ biochemically and
histologically. Tumors, characterized by unregulated mul-
tiplication of cells, need an increasing supply of essential
nutrients, including trace elements. This probably results in
an increased vascularity of malignant tissues, which in turn
leads to enhancement of elemental concentrations in
tumors. The malignant process that has already started can
result in a lowered concentration of microelements, which
is shown in our studies for Mn, Cu, and Zn (Figs. 4, 6, 7)
for all Gleason groups. The lowering of elemental content
in tumorous tissue indicates the transport changes for some
elements and a number of channels of the cell membrane.
The results obtained testify the promising nature of the
study for understanding tissue degradation processes. The
considerations relating to Gleason grading have called for
the development of diagnostic tools that operate on the
basis of cellular biochemical rather than visual tissue
architectural recognition. Maybe manipulation of trace
elements will provide new lines of treatment for cancers. It
is clear that further studies with a larger number of tissue
samples must be performed to consolidate the present
conclusions. Moreover, the analysis and classiﬁcation
method presented in this work can be reﬁned in the future,
including the use of other types of tissues.
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